CPC in Adult Refractory Glaucoma
Evaluation of Diode Laser Cyclophotocoagulation in Adult Refractory Glaucoma
1 other identifier
interventional
25
1 country
1
Brief Summary
The purpose of this study is to assess the relative effectiveness and safety of diode laser cyclophotocoagulation procedure to reduce IOP and relieve pain in adult patients with refractory glaucoma.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 30, 2021
CompletedFirst Posted
Study publicly available on registry
June 10, 2021
CompletedStudy Start
First participant enrolled
July 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2022
CompletedJanuary 11, 2022
January 1, 2022
9 months
May 30, 2021
January 9, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
change in intraocular pressure
IOP measuring using Goldmann applanation tonometer.
First day postoperative and 1 week
Study Arms (1)
Refractory glaucoma
EXPERIMENTALInterventions
A handpiece (G probe) is used to deliver the diode laser energy with a wavelength of 810 nm.
Eligibility Criteria
You may qualify if:
- Patients with refractory glaucoma aging 18 years and older.
- Both sexes are included.
- Patients Capable of giving informed consent.
- Pseudophkic glaucoma.
- Aphakic glaucoma.
- Silicon oil induced glaucoma.
- Neovascular glaucoma.
- Inflammatory glaucoma.
You may not qualify if:
- Patients \<18 years of age.
- Patients controlled on regular antiglaucomatous therapy.
- Patients who cannot do regular follow up visits.
- Diffuse scleral staphyloma at the site of CPC.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sohag Universitylead
Study Sites (1)
Sohag University
Sohag, Egypt
Related Publications (3)
Ansari E, Gandhewar J. Long-term efficacy and visual acuity following transscleral diode laser photocoagulation in cases of refractory and non-refractory glaucoma. Eye (Lond). 2007 Jul;21(7):936-40. doi: 10.1038/sj.eye.6702345. Epub 2006 Apr 21.
PMID: 16628239BACKGROUNDLai JS, Tham CC, Chan JC, Lam DS. Diode laser transscleral cyclophotocoagulation in the treatment of chronic angle-closure glaucoma: a preliminary study. J Glaucoma. 2003 Aug;12(4):360-4. doi: 10.1097/00061198-200308000-00011.
PMID: 12897582BACKGROUNDNassiri N, Kamali G, Rahnavardi M, Mohammadi B, Nassiri S, Rahmani L, Nassiri N. Ahmed glaucoma valve and single-plate Molteno implants in treatment of refractory glaucoma: a comparative study. Am J Ophthalmol. 2010 Jun;149(6):893-902. doi: 10.1016/j.ajo.2010.01.025. Epub 2010 May 8.
PMID: 20451896BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
May 30, 2021
First Posted
June 10, 2021
Study Start
July 1, 2021
Primary Completion
April 1, 2022
Study Completion
April 1, 2022
Last Updated
January 11, 2022
Record last verified: 2022-01